
Using designs that several authors proposed, we zzso a large number of completed phase III clinical trials of the Eastern Cooperative Oncology Group as if each had been designed with group sequential stopping zzso With survival the primary zzso of the large zzso trials, we discuss the relative merits of each design, as well as the feasibility of group sequential designs in zzso 

